SECTION 1
Historical Context & Motivation
Pressure injuries — formerly referred to as pressure ulcers, decubitus ulcers, or bedsores — have been documented since antiquity, yet a rigorous understanding of their pathophysiology has only crystallized over the last century. Ancient Egyptian mummies show evidence of soft-tissue breakdown over bony prominences, indicating that immobility-related wounds have plagued human populations for millennia. Despite this long history, pressure injuries remain one of the most common and costly complications in modern healthcare, affecting an estimated 2.5 million patients annually in the United States alone and contributing to roughly 60,000 deaths each year. The persistence of this problem underscores the importance of understanding the underlying mechanisms and risk factors so that clinicians can implement evidence-based prevention strategies.
The scientific investigation of pressure-induced tissue damage evolved from descriptive clinical observations to mechanistic laboratory research. Early physicians recognized that prolonged bed rest caused skin breakdown, but lacked the physiological framework to explain why. The development of capillary physiology, biomechanics, and nutritional science in the twentieth century provided the conceptual tools needed to dissect the multifactorial etiology of these injuries. Today, we understand that pressure injuries result from a complex interplay of mechanical forces, ischemia-reperfusion injury, lymphatic impairment, and patient-specific intrinsic vulnerabilities.
1593 • Fabricius Hildanus — Early Clinical Description
1873 • Charcot and the Neurotrophic Theory
1930 • Landis — Capillary Closing Pressure
1975 • Daniel et al. — Deep Tissue Injury Concept
2016 • NPUAP Reclassification
The central question that drives modern pressure injury science is deceptively simple: how does sustained mechanical load translate into cellular death and tissue necrosis? Answering this question requires integrating knowledge from vascular physiology, cell biology, biomechanics, and clinical medicine. Equally important is understanding why certain patients are disproportionately vulnerable — a question addressed by examining the intrinsic and extrinsic risk factors that modulate tissue tolerance.
SECTION 2
Core Principles & Definitions
A pressure injury is defined as localized damage to the skin and underlying soft tissue, usually over a bony prominence or related to a medical device, resulting from sustained or intense pressure or pressure in combination with shear. The injury occurs because external forces exceed the tissue's inherent ability to maintain perfusion and structural integrity — a concept encapsulated by the term tissue tolerance. Understanding pressure injury pathophysiology requires mastery of several foundational principles that connect mechanical loading to cellular injury.
Pressure & Capillary Occlusion
Shear & Tissue Deformation
Ischemia-Reperfusion Injury
Lymphatic Impairment & Edema
Tissue Tolerance
KEY TAKEAWAY
SECTION 3
Visual Explanation — The Pathophysiology Cascade
The development of a pressure injury follows a predictable pathophysiological cascade, beginning with external mechanical loading and progressing through ischemia, cellular injury, inflammatory amplification, and tissue necrosis. The following diagram illustrates this cascade, emphasizing the dual pathways of direct deformation injury and ischemia-reperfusion injury that converge to produce clinical tissue damage.
Critically, these two pathways are not mutually exclusive — they operate simultaneously and synergistically. In clinical practice, a patient lying on a sacrum with the head of the bed elevated experiences perpendicular compressive pressure and tangential shear forces simultaneously, meaning both ischemic and deformation pathways are activated concurrently. The inflammatory cascade amplifies initial injury through recruitment of neutrophils, release of proteolytic enzymes, and further generation of reactive oxygen species, creating a positive feedback loop that can extend the zone of damage well beyond the original area of mechanical loading.
SECTION 4
Mechanism — Pressure-Duration Relationship & Tissue Vulnerability
The relationship between pressure magnitude and duration of exposure is fundamental to understanding pressure injury development. Research has established an inverse relationship between pressure intensity and the time required to produce tissue damage: higher pressures cause injury more rapidly, while lower pressures require extended duration to produce equivalent damage. This principle was first quantified by Reswick and Rogers (1976) in their classic pressure-time tolerance curve, which remains a foundational concept in pressure injury prevention.
CAPILLARY CLOSING PRESSURE CONCEPT
When Pexternal exceeds the intraluminal capillary pressure, the vessel collapses and blood flow ceases. Landis's 32 mmHg value, while widely cited, represents a healthy, well-perfused individual; actual capillary closing pressures vary with patient comorbidities and local tissue conditions.
INTERFACE PRESSURE DISTRIBUTION
The basic relationship governing interface pressure. A 70 kg patient supported on a small bony prominence (e.g., ischial tuberosity with contact area ≈ 15 cm²) will experience far greater pressure per unit area than the same patient on a broad surface. This explains why pressure injuries cluster at bony prominences: the body's weight is concentrated over a minimal contact area, producing focal pressure that far exceeds capillary closing thresholds.
Tissue Vulnerability Hierarchy
Not all tissues are equally susceptible to pressure-induced damage. The classic research by Daniel et al. (1975) established that muscle is the most sensitive tissue to ischemia, followed by subcutaneous fat, dermis, and finally epidermis. This hierarchy has profound clinical implications: a pressure injury may begin with extensive deep muscle necrosis while the overlying skin appears relatively intact — a phenomenon now recognized as deep tissue pressure injury (DTPI). Muscle's high metabolic rate demands continuous oxygen and glucose delivery, making it exquisitely vulnerable to even brief periods of ischemia. The pressure distribution within tissues follows a cone-shaped gradient, with the highest pressure concentrated at the bone-muscle interface and decreasing toward the skin surface. This means the deep tissues adjacent to bony prominences experience significantly greater compressive stress than the skin surface, explaining why the visible skin lesion often underestimates the true extent of underlying tissue destruction.
Clinical Correlation
SECTION 5
Risk Factor Classification — Intrinsic & Extrinsic
Risk factors for pressure injury development are traditionally organized into two broad categories: intrinsic factors (related to the patient's physiology and health status) and extrinsic factors (related to the patient's environment and external mechanical forces). This classification informs clinical risk assessment tools such as the Braden Scale, Norton Scale, and Waterlow Score, which systematically evaluate these factors to stratify patients by risk level. Understanding these factors is essential for developing targeted prevention strategies, as effective prevention requires addressing both modifiable and non-modifiable contributors.
Key Intrinsic Risk Factors in Detail
| Risk Factor | Pathophysiological Mechanism | Clinical Example |
|---|---|---|
| Immobility | Eliminates spontaneous repositioning that normally redistributes pressure; sustained loading leads to unrelieved ischemia | Spinal cord injury, sedated ICU patients, hip fracture patients post-operatively |
| Malnutrition | Depleted serum albumin (< 3.5 g/dL) reduces oncotic pressure and tissue repair capacity; deficiency in vitamin C impairs collagen synthesis; protein-calorie malnutrition reduces subcutaneous padding | Elderly with unintentional weight loss, cancer cachexia, chronic illness |
| Aging | Thinning epidermis, flattened dermal-epidermal junction, decreased collagen and elastin, reduced subcutaneous fat, impaired microcirculation, diminished inflammatory response | Patients ≥ 70 years old; particularly those with multiple comorbidities |
| Sensory Impairment | Loss of pain and pressure sensation eliminates the protective feedback loop that triggers repositioning; patients cannot perceive ischemic discomfort | Diabetic neuropathy, spinal cord injury, stroke with hemisensory loss |
| Perfusion Deficits | Peripheral vascular disease, hypotension, vasopressor use, or cardiac failure reduce baseline tissue perfusion, lowering the effective capillary closing pressure threshold | Sepsis-related hypotension, heart failure, patients on norepinephrine infusions |
Major intrinsic risk factors, their pathophysiological mechanisms, and representative clinical examples.
Key Extrinsic Risk Factors in Detail
Moisture from urinary or fecal incontinence, perspiration, or wound exudate weakens the skin's barrier function through maceration, making it more susceptible to friction and shear. Macerated skin has reduced tensile strength and is more permeable to irritants and microorganisms. Friction — the resistance to sliding between two surfaces — strips away the epidermis, producing superficial skin loss that, while not a pressure injury per se, compromises the skin's protective function and predisposes to deeper injury. Medical device-related pressure injuries have emerged as a significant concern, particularly in critical care settings. Endotracheal tubes, nasogastric tubes, cervical collars, oxygen masks, pulse oximeters, and sequential compression devices can all generate localized pressure that exceeds tissue tolerance, especially when devices are not regularly repositioned or properly sized.
SECTION 6
Worked Example — Clinical Risk Assessment
The following clinical scenario demonstrates how to systematically identify risk factors and apply pathophysiological reasoning to a patient assessment for pressure injury risk. We will use a modified Braden Scale assessment to illustrate the integration of intrinsic and extrinsic risk factors.
Clinical Scenario
Pressure Injury Risk Assessment — Mr. J.
- 1
Step 1 — Identify Intrinsic Risk Factors
Systematically evaluate patient-related factors that reduce tissue tolerance. Mr. J. presents with multiple compounding intrinsic risks: advanced age (78 years) — reduced dermal thickness, impaired collagen synthesis, diminished subcutaneous fat padding; malnutrition (BMI 18.2, albumin 2.6 g/dL) — protein-calorie deficit impairs tissue repair and reduces subcutaneous cushioning; peripheral arterial disease + diabetes — compromised microvascular perfusion and neuropathy; vasopressor use (norepinephrine) — peripheral vasoconstriction further reduces tissue perfusion; sedation — eliminates spontaneous repositioning and sensory feedback.At least 6 major intrinsic risk factors identified — each independently reduces tissue tolerance - 2
Step 2 — Identify Extrinsic Risk Factors
Next, evaluate the external forces and environmental conditions contributing to mechanical loading. Sustained pressure: 4 hours without repositioning on a standard mattress — the sacrum, heels, and occiput are under continuous load. Inadequate support surface: a standard hospital mattress provides insufficient pressure redistribution for a high-risk patient. Medical devices: endotracheal tube, Foley catheter tubing, pulse oximeter, and potential cervical collar or nasal gastric tubes create localized pressure points.3 major extrinsic risk factors — all potentially modifiable through nursing intervention - 3
Step 3 — Apply Braden Scale Assessment
The Braden Scale evaluates six subscales, each scored 1–4 (lower = higher risk), with a maximum total of 23. Sensory Perception: 1 (completely limited — sedated, cannot respond to pain); Moisture: 3 (occasionally moist — Foley prevents urine contact but perspiration possible); Activity: 1 (bedfast); Mobility: 1 (completely immobile — sedated); Nutrition: 1 (very poor — albumin 2.6, BMI 18.2, NPO post-surgery); Friction & Shear: 1 (problem — requires maximal assistance, slides in bed).Total Braden Score: 8 out of 23 — Severe Risk (≤ 9 indicates highest risk category) - 4
Step 4 — Apply Pathophysiological Reasoning
Integrate the risk factors with the pathophysiology cascade. Mr. J.'s norepinephrine-mediated vasoconstriction reduces baseline capillary perfusion pressure, meaning tissue ischemia begins at lower external pressures than normal. His diabetes-related microvascular disease compounds this by impairing capillary autoregulation. The low albumin reduces plasma oncotic pressure, promoting interstitial edema that increases oxygen diffusion distances. His low BMI means minimal subcutaneous fat padding over bony prominences, concentrating pressure forces. The combination of sedation and immobility means no spontaneous weight-shifting occurs, allowing sustained unrelieved ischemia.Synergistic risk: tissue tolerance is profoundly reduced while mechanical load is unmitigated — pressure injury development is highly likely without immediate intervention - 5
Step 5 — Formulate Prevention Plan
Target modifiable factors: upgrade to a pressure-redistribution support surface (alternating pressure or low-air-loss mattress); implement q2h repositioning protocol with micro-shifts; apply heel suspension devices; assess and pad all medical devices; initiate nutritional consultation for protein supplementation; apply moisture barrier cream; document skin assessment every shift with particular attention to the sacrum, heels, occiput, and device contact points.Multimodal prevention addressing both intrinsic optimization and extrinsic force reduction
SECTION 7
Comparison of Risk Assessment Tools
Several validated risk assessment instruments have been developed to standardize pressure injury risk evaluation across clinical settings. Each tool emphasizes different risk factors and utilizes distinct scoring methodologies, reflecting their development in different patient populations and care environments. Understanding the strengths and limitations of these tools enables clinicians to select the most appropriate instrument for their practice context and to interpret scores within the broader clinical picture.
| Feature | Braden Scale | Norton Scale | Waterlow Score |
|---|---|---|---|
| Year Developed | 1987 (Bergstrom & Braden) | 1962 (Doreen Norton) | 1985 (Judy Waterlow) |
| Subscales | 6: Sensory perception, Moisture, Activity, Mobility, Nutrition, Friction/Shear | 5: Physical condition, Mental state, Activity, Mobility, Incontinence | 11+: BMI, Age, Sex, Skin type, Continence, Mobility, Appetite, Tissue malnutrition, Neurological deficit, Surgery, Medications |
| Scoring Direction | Lower score = Higher risk (range 6–23; ≤ 18 = at risk) | Lower score = Higher risk (range 5–20; ≤ 14 = at risk) | Higher score = Higher risk (≥ 10 = at risk; ≥ 15 = high risk; ≥ 20 = very high risk) |
| Strengths | Most extensively validated; includes nutrition and friction/shear; high interrater reliability; widely used globally | Simple and quick to administer; good for screening in geriatric populations | Most comprehensive; includes surgical risk, medications, and tissue malnutrition markers; widely used in UK |
| Limitations | May over-predict risk (high sensitivity, lower specificity); does not account for surgical risk or medications | Does not assess nutrition or moisture; limited validation data; less sensitive than Braden | Complex; lower interrater reliability due to subjective scoring; may over-predict in some populations |
Comparison of three major pressure injury risk assessment tools used in clinical practice.
KEY TAKEAWAY
SECTION 8
Staging System & Connections to Advanced Clinical Concepts
The pathophysiological mechanisms discussed in this lesson directly inform the clinical staging of pressure injuries, as each stage reflects a progressively deeper zone of tissue destruction corresponding to the duration and intensity of mechanical loading and the patient's tissue tolerance. Understanding how cellular and vascular injury translates into visible tissue damage is essential for accurate staging and appropriate wound management.
| Stage | Tissue Involvement | Pathophysiology Connection |
|---|---|---|
| Stage 1 | Intact skin with non-blanchable erythema; represents early inflammatory response without tissue loss | Reactive hyperemia that does not resolve — indicates local ischemia-reperfusion has triggered inflammatory mediators but tissue remains structurally intact |
| Stage 2 | Partial-thickness loss of dermis; presents as shallow open ulcer or intact/ruptured serum-filled blister | Epidermal and superficial dermal cell death from combined ischemia and mechanical disruption; friction often contributes to this stage |
| Stage 3 | Full-thickness tissue loss; subcutaneous fat may be visible; bone, tendon, muscle NOT exposed | Ischemic necrosis extends through full dermis into subcutaneous tissue; slough or eschar may be present; depth varies by anatomical location |
| Stage 4 | Full-thickness tissue loss with exposed bone, tendon, or muscle; may include undermining and tunneling | Extensive necrosis from the cone-shaped pressure gradient — deepest damage at bone-tissue interface confirms the deep-to-superficial injury progression model |
| Unstageable | Full-thickness tissue loss obscured by slough or eschar; true depth cannot be determined until debrided | Necrotic tissue (eschar/slough) is the end product of coagulative necrosis from sustained ischemia; it must be removed to reveal the wound bed |
| Deep Tissue Pressure Injury | Intact or non-intact skin with localized area of persistent non-blanchable deep red, maroon, or purple discoloration, or epidermal separation revealing a dark wound bed | Directly reflects the tissue vulnerability hierarchy — muscle and deep tissue sustain ischemic damage before superficial layers; the 'iceberg' effect where surface findings underrepresent deep destruction |
NPUAP/EPUAP Staging System with pathophysiological correlations.
Advanced clinical concepts that build on this foundational pathophysiology include the study of biofilm formation in chronic pressure injuries (where microbial communities establish protective extracellular matrices that resist host immune responses and antimicrobial treatment), molecular biomarkers for early detection of sub-clinical tissue injury (including sub-epidermal moisture measurement and inflammatory cytokine panels), and computational modeling using finite element analysis to predict internal tissue stress distributions based on patient body habitus and support surface characteristics. These advancing areas of research promise to transform pressure injury prevention from a reactive, population-level screening approach to a proactive, individualized risk-prediction model.
SECTION 9
Practice Problems
Question 1: CONCEPTUAL
Show answer
Question 2: BASIC CALCULATION
Show answer
Question 3: INTERMEDIATE
Show answer
Question 4: APPLIED
Show answer
Question 5: CRITICAL THINKING
Show answer
SUMMARY
Lesson Summary
Summary
Pressure injuries result from localized tissue damage caused by sustained or intense mechanical loading (pressure, shear, and friction), typically over bony prominences or beneath medical devices. The pathophysiology involves two converging pathways: ischemia-reperfusion injury (capillary occlusion → hypoxia → reperfusion ROS damage) and direct cellular deformation (cytoskeletal disruption and membrane damage). The tissue vulnerability hierarchy — muscle > subcutaneous fat > dermis > epidermis — explains why deep tissue pressure injuries can present with intact overlying skin, and the cone-shaped pressure gradient concentrates maximum stress at the bone-tissue interface.
Risk factors are classified as intrinsic (immobility, malnutrition, aging, sensory impairment, perfusion deficits, neurological impairment) and extrinsic (sustained pressure, shear, friction, moisture, medical devices, inadequate support surfaces). Validated assessment tools — the Braden Scale, Norton Scale, and Waterlow Score — systematically evaluate these factors to stratify patients by risk level, but clinical judgment must always supplement standardized scoring. Effective prevention targets modifiable risk factors through pressure redistribution, repositioning protocols, nutritional optimization, moisture management, skin assessment, and device monitoring — strategies grounded in the pathophysiological principles that define how and why these injuries develop.